中文 | EN | 日本語
決算資料 最新の開示

RedHill Biopharma Ltd.(RDHL)適時開示・決算発表

查看完整財經日曆 →

提出日様式項目原文
2026-08-07 6-K SEC
2026-08-06 6-K SEC
2026-07-28 6-K SEC
2026-07-01 6-K SEC
2026-06-29 6-K SEC
2026-06-25 6-K SEC
2026-06-22 6-K SEC
2026-06-22 6-K SEC
2026-06-22 6-K SEC
2026-06-18 6-K SEC
2026-06-09 6-K SEC
2026-06-08 6-K SEC
2026-06-02 6-K SEC
2026-05-27 6-K SEC
2026-04-30 6-K SEC
2026-04-27 6-K SEC
2026-04-22 6-K SEC
2026-04-14 6-K SEC
2026-03-05 6-K SEC
2026-02-25 6-K SEC
2026-01-27 6-K SEC
2026-01-22 6-K SEC
2026-01-05 6-K SEC
2025-12-31 6-K SEC
2025-12-23 6-K SEC
2025-12-15 6-K SEC
2025-12-01 6-K SEC
2025-11-26 6-K SEC
2025-11-04 6-K SEC
2025-10-22 6-K SEC
2025-10-21 6-K SEC
2025-10-20 6-K SEC
2025-10-06 6-K SEC
2025-09-29 6-K SEC
2025-09-05 6-K SEC
2025-08-20 6-K SEC
2025-08-18 6-K SEC
2025-08-14 6-K SEC
2025-07-21 6-K SEC
2025-07-01 6-K SEC
2025-06-25 6-K SEC
2025-05-27 6-K SEC
2025-05-19 6-K SEC
2025-05-13 6-K SEC
2025-05-05 6-K SEC
2025-05-02 6-K SEC
2025-04-28 6-K SEC
2025-04-17 6-K SEC
2025-04-16 6-K SEC
2025-04-10 6-K SEC
2025-04-08 6-K SEC
2025-04-01 6-K SEC
2025-03-26 6-K SEC
2025-03-18 6-K SEC
2025-03-12 6-K SEC
2025-02-27 6-K SEC
2025-02-25 6-K SEC
2025-02-04 6-K SEC
2025-02-03 6-K SEC
2025-01-21 6-K SEC

出典は SEC EDGAR の 8-K/6-K。8-K は米国内企業の臨時報告(Item 2.02 が決算発表)、6-K は外国企業(ADR 含む)の対応様式です。当サイトはリンクの整理のみ行い、原文はすべて sec.gov にあります。